illicit

FDA Approves Phase 3 Clinical Trial of Ecstasy for PTSD Sufferers

The FDA gave permission on November 29 for large-scale, Phase 3 clinical trials of Ecstasy for people suffering with post-traumatic stress disorder, or PTSD. Many people swear the currently-illicit street drug has saved their lives, and if the trial is successful, it would establish Ecstasy as a legitimate prescription drug. [1]
Preliminary trials of Ecstasy, also called MDMA, for PTSD have been successful, but a large-scale trial is necessary before the FDA can approve it. [2]

Sharing a Room With an Infant can Help Guard Against SIDS

In a policy statement released October 24, the American Academy of Pediatrics (AAP) recommends that infants should sleep in the same room as parents to lower the risk of sleep-related deaths. [1]
The group, which offers guidance on child-rearing, says that newborns should be placed to sleep in their parents’ bedroom on a separate, firm surface, such as a crib or bassinet, for at least the first 6 months of life and, ideally, the first full year.